ONO-4915
/ Ono Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 17, 2026
ONO-4915 in Patients With Primary Sjogren's Disease
(clinicaltrials.gov)
- P2 | N=60 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co., Ltd.
IO biomarker • New P2 trial • Sjogren's Syndrome
1 to 1
Of
1
Go to page
1